Biocon Biologics and Civica, Inc. (Civica), a not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, today ...

Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.

Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration ...

This collaboration is in addition to Biocon Biologics’ own insulin aspart drug product for the US, which is currently under ...

Biocon Biologics partners with Civica Inc to increase affordability and access to Insulin Aspart in the US, targeting the ...

Biocon Biologics on Thursday said it has tied up with not-for-profit generic drug and pharmaceutical firm Civica, Inc to expand access and affordability of Insulin Aspart in the US.

Type 2 diabetes is a chronic disease linked to severe health complications, including cardiovascular diseases and increased mortality. While genetics, obesity, and lifestyle factors are known risk ...

A study from Tübingen reveals that the brain plays a central role in the development of obesity. The prevalence of obesity ...

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

The Right Diet for PCOD Your diet has a significant impact on hormone balance. A PCOD-friendly diet should concentrate on ...

Insulet (NASDAQ:PODD – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...